2016 annual financial data
Nektar Therapeutics 2016 Operating margin
Nektar Therapeutics 2016 operating margin with verified reported values.
Direct answer
Operating margin was -68.22%.
Operating income was -112,855,000 USD and net income was -153,524,000 USD.
Operating cash flow was -117,024,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 165,436,000 USD
- Operating income
- -112,855,000 USD
- Net income
- -153,524,000 USD
- Operating cash flow
- -117,024,000 USD